Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.

MLA

Graham, Susan, et al. “Cognitive Function in Ambulatory Patients with Systolic Heart Failure: Insights from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial.” PloS One, vol. 9, no. 11, Nov. 2014, p. e113447. EBSCOhost, https://doi.org/10.1371/journal.pone.0113447.

APA

Graham, S., Ye, S., Qian, M., Sanford, A. R., Di Tullio, M. R., Sacco, R. L., Mann, D. L., Levin, B., Pullicino, P. M., Freudenberger, R. S., Teerlink, J. R., Mohr, J. P., Labovitz, A. J., Lip, G. Y. H., Estol, C. J., Lok, D. J., Ponikowski, P., Anker, S. D., Thompson, J. L. P., & Homma, S. (2014). Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial. PloS One, 9(11), e113447. https://doi.org/10.1371/journal.pone.0113447

Chicago

Graham, Susan, Siqin Ye, Min Qian, Alexandra R Sanford, Marco R Di Tullio, Ralph L Sacco, Douglas L Mann, et al. 2014. “Cognitive Function in Ambulatory Patients with Systolic Heart Failure: Insights from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial.” PloS One 9 (11): e113447. doi:10.1371/journal.pone.0113447.